182 related articles for article (PubMed ID: 27281989)
41. Yersinia's stratagem: targeting innate and adaptive immune defense.
Heesemann J; Sing A; Trülzsch K
Curr Opin Microbiol; 2006 Feb; 9(1):55-61. PubMed ID: 16413818
[TBL] [Abstract][Full Text] [Related]
42. TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors.
Iriarte M; Sory MP; Boland A; Boyd AP; Mills SD; Lambermont I; Cornelis GR
EMBO J; 1998 Apr; 17(7):1907-18. PubMed ID: 9524114
[TBL] [Abstract][Full Text] [Related]
43. Regulation of the Yersinia type III secretion system: traffic control.
Dewoody RS; Merritt PM; Marketon MM
Front Cell Infect Microbiol; 2013; 3():4. PubMed ID: 23390616
[TBL] [Abstract][Full Text] [Related]
44. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
[TBL] [Abstract][Full Text] [Related]
45. Rejection of impassable substrates by Yersinia type III secretion machines.
Sorg JA; Miller NC; Marketon MM; Schneewind O
J Bacteriol; 2005 Oct; 187(20):7090-102. PubMed ID: 16199580
[TBL] [Abstract][Full Text] [Related]
46. Acting on Actin: Rac and Rho Played by Yersinia.
Aepfelbacher M; Wolters M
Curr Top Microbiol Immunol; 2017; 399():201-220. PubMed ID: 27744508
[TBL] [Abstract][Full Text] [Related]
47. Modulation of Rho GTPases and the actin cytoskeleton by YopT of Yersinia.
Aepfelbacher M; Zumbihl R; Heesemann J
Curr Top Microbiol Immunol; 2005; 291():167-75. PubMed ID: 15981463
[TBL] [Abstract][Full Text] [Related]
48. Type III machines of pathogenic yersiniae secrete virulence factors into the extracellular milieu.
Lee VT; Schneewind O
Mol Microbiol; 1999 Mar; 31(6):1619-29. PubMed ID: 10209737
[TBL] [Abstract][Full Text] [Related]
49. The Yersinia enterocolitica type 3 secretion system (T3SS) as toolbox for studying the cell biological effects of bacterial Rho GTPase modulating T3SS effector proteins.
Wölke S; Ackermann N; Heesemann J
Cell Microbiol; 2011 Sep; 13(9):1339-57. PubMed ID: 21718421
[TBL] [Abstract][Full Text] [Related]
50. Methods for Detection of Pyrin Inflammasome Assembly in Macrophages Infected with Yersinia spp.
Medici NP; Bliska JB
Methods Mol Biol; 2019; 2010():241-255. PubMed ID: 31177443
[TBL] [Abstract][Full Text] [Related]
51. Type III secretion translocon assemblies that attenuate Yersinia virulence.
Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
[TBL] [Abstract][Full Text] [Related]
52. Current activities of the Yersinia effector protein YopM.
Höfling S; Grabowski B; Norkowski S; Schmidt MA; Rüter C
Int J Med Microbiol; 2015 May; 305(3):424-32. PubMed ID: 25865799
[TBL] [Abstract][Full Text] [Related]
53. Yersinia outer protein P suppresses TGF-beta-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells.
Haase R; Richter K; Pfaffinger G; Courtois G; Ruckdeschel K
J Immunol; 2005 Dec; 175(12):8209-17. PubMed ID: 16339560
[TBL] [Abstract][Full Text] [Related]
54. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
Francis MS; Wolf-Watz H
Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
[TBL] [Abstract][Full Text] [Related]
55. Yersinia virulence: more than a plasmid.
Revell PA; Miller VL
FEMS Microbiol Lett; 2001 Dec; 205(2):159-64. PubMed ID: 11750796
[TBL] [Abstract][Full Text] [Related]
56. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
Edqvist PJ; Aili M; Liu J; Francis MS
Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
[TBL] [Abstract][Full Text] [Related]
57. The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation.
Soundararajan V; Patel N; Subramanian V; Sasisekharan V; Sasisekharan R
Innate Immun; 2011 Dec; 17(6):548-57. PubMed ID: 20699282
[TBL] [Abstract][Full Text] [Related]
58. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
[TBL] [Abstract][Full Text] [Related]
59. Role of the Yersinia YopJ protein in suppressing interleukin-8 secretion by human polymorphonuclear leukocytes.
Spinner JL; Hasenkrug AM; Shannon JG; Kobayashi SD; Hinnebusch BJ
Microbes Infect; 2016 Jan; 18(1):21-9. PubMed ID: 26361732
[TBL] [Abstract][Full Text] [Related]
60. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
